BioAdvance Capital (Conshohocken)

Venture capital · Conshohocken, Pennsylvania

BioAdvance Capital (Conshohocken) is a venture capital firm based in Conshohocken, Pennsylvania. Founded in 2002, BioAdvance Captial is a venture capital firm headquartered in Conshohocken, Pennsylvania. 19 portfolio companies are on record.

AUM
$70.0M
Portfolio companies
19
Recorded deals
170
11 in last 12M
Last investment
—

BioAdvance Capital (Conshohocken) key facts

  • BioAdvance Capital (Conshohocken) is a venture capital firm based in Conshohocken, Pennsylvania with 19 tracked portfolio companies.
  • Notable positions include ImmunoGenesis, Ordaos, iView Therapeutics.

About BioAdvance Capital (Conshohocken)

Founded in 2002, BioAdvance Captial is a venture capital firm headquartered in Conshohocken, Pennsylvania. The firm prefers to invest in early-stage companies operating in the healthcare and life sciences, focusing on therapeutics, medical devices, research tools, diagnostics, and health information technology in the mid-Atlantic region between New York City and Washington, DC.

BioAdvance Capital (Conshohocken) portfolio at a glance

19 portfolio companies are on record for BioAdvance Capital (Conshohocken), including ImmunoGenesis, Ordaos and iView Therapeutics.

12 of the 19 carry a recorded valuation.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 19 recorded positions
  • ·Watchlist + alerts for BioAdvance Capital (Conshohocken)'s activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

19 companies · priced for members
CompanyValuationRole
ImmunoGenesis▮▮
Ordaos▮▮
iView Therapeutics▮▮
+ 16 more companies · all 19, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Frequently asked about BioAdvance Capital (Conshohocken)

What companies does BioAdvance Capital (Conshohocken) invest in?
BioAdvance Capital (Conshohocken) has 19 recorded portfolio companies, including ImmunoGenesis, Ordaos, iView Therapeutics.
What is BioAdvance Capital (Conshohocken)'s AUM?
BioAdvance Capital (Conshohocken) manages approximately $70.0M in assets.